Uncategorized
Publication Exclusive: Xiidra takes the stage: Keenly anticipated medicine available to treat dry eye disease
Well, Labor Day has come and gone, so I guess it is time for my annual September lifitegrast — now Xiidra — column. After what seemed like forever, the FDA approved Xiidra in July for the treatment of both the signs and symptoms of DED. I have had the opportunity to use it for about 6 weeks. Why don’t we take a little bit of time and review what it is, how it works and how you can integrate it into your DED protocols in the near term.In the DED (Read more...)